BridgeBio Oncology Therapeutics Inc. (BBOT) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BridgeBio Oncology Therap...

    NASDAQ: BBOT · Real-Time Price · USD
    12.36
    -0.08 (-0.64%)
    At close: Oct 03, 2025, 3:59 PM
    12.60
    1.94%
    After-hours: Oct 03, 2025, 07:57 PM EDT

    BridgeBio Oncology Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q4 2022
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Dec 31, 2022
    Net Income
    		 918.31K -487.39K 1.95M 2.33M 2.21M 1.1M -41.69K -3.52K
    Depreciation & Amortization
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Stock-Based Compensation
    		 36K 57.92K 77.4K 77.4K 77.4K 39.37K n/a n/a
    Other Working Capital
    		 n/a 20.24K 22.75K 347.05K 123.24K -470.3K n/a n/a
    Other Non-Cash Items
    		 -1.25M -325.41K -2.25M -2.79M -2.44M -1.25M n/a n/a
    Deferred Income Tax
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Change in Working Capital
    		 n/a 20.24K 127.45K 347.05K 123.24K -470.3K n/a n/a
    Operating Cash Flow
    		 -298.9K -734.64K -87.86K -28.86K -29.1K -618K n/a n/a
    Capital Expenditures
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a 184M n/a -184M n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a n/a -184M n/a n/a
    Investing Cash Flow
    		 n/a n/a n/a 184M n/a -184M n/a n/a
    Debt Repayment
    		 n/a n/a 209.85K n/a n/a -209.85K n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a 187.04M n/a n/a -578.55K n/a n/a
    Financial Cash Flow
    		 n/a n/a n/a n/a n/a 186.46M n/a n/a
    Net Cash Flow
    		 -298.9K -734.64K -87.86K -28.86K -29.1K 1.84M n/a n/a
    Free Cash Flow
    		 -298.9K -734.64K -87.86K -28.86K -29.1K -618K n/a n/a

    Add to Watchlist